Clinical trial
Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)
NCT00436345 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00436345 |
|---|---|
| Title | Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) |
| Official title | A Randomized, Open Label, Multicentre Study to Compare the Pharmaco-economic Implications of an Analgesia Based Regimen With Remifentanil and a Conventional Sedation Based Regimen Using Propofol in Medical and Post-surgical ICU Subjects Requiring Mechanical Ventilation for at Least 2 Days. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Analgesia |
| Intervention type | Drug |
| Interventions | Remifentanil, Propofol |
| Enrollment | 39 |
| Start date | Nov 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 19, 2007 |
| Last update posted | May 30, 2017 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: